Sarcome des tissus mous de l'adulte : retour sur une décennieBLAY, J.-Y.Oncologie (Paris). 2011, Vol 13, Num 12, issn 1292-3818, 26 p., SUP6Serial Issue

Pharmacological management of gastrointestinal stromal tumours: an update on the role of sunitinibBLAY, J.-Y.Annals of oncology. 2010, Vol 21, Num 2, pp 208-215, issn 0923-7534, 8 p.Article

Médicaments actuels et optimisation = Optimizing current drugsBLAY, J.-Y.Annales pharmaceutiques françaises. 2005, Vol 63, Num 1, pp 17-24, issn 0003-4509, 8 p.Conference Paper

Les lymphomes malins non hodgkiniens cérébraux primitifs des patients non immunodéprimés = Primary non hodgkin's lymphoma of the brain in non immunosuppressed patientsBLAY, J.-Y.Bulletin du cancer. 1997, Vol 84, Num 10, pp 976-980, issn 0007-4551Article

Les cancers associés au sida = Cancer associated with AIDSBLAY, J.-Y; BOUHOUR, D.Bulletin du cancer. 1999, Vol 86, Num 1, pp 53-56, issn 0007-4551Article

Facteur de nécrose tumorale alpha (cachectine): propriétés biologiques et rôle en physiopathologie = Tumor necrosis factor alpha (cachectin). Biological properties and role in physiopathologyBLAY, J. Y; CHOUAIB, S.La Presse médicale (1983). 1989, Vol 18, Num 19, pp 975-979, issn 0755-4982, 5 p.Article

Intérêt du cis-platinum à forte dose dans le traitement du mésothéliome malin pleural: une observation = High dose cis-platinum in the treatment of pleural malignant mesotheliomaBLAY, J. Y; REBATTU, P.Revue de pneumologie clinique (Paris). 1988, Vol 44, Num 1, issn 0761-8417, 54Article

Thérapies ciblées et immunomodulation dans les tumeurs solides : Médecine interne-Oncologie = Targeted therapies and immunomodulation in solid tumoursFAYENE, J; BLAY, J.-Y.Réanimation (Paris. 2001). 2006, Vol 15, Num 4, pp 297-302, issn 1624-0693, 6 p.Article

Le carcinome à cellules de Merkel: diagnostic, traitement de la maladie locorégionale et e la maladie en phase métastatique = Merkel cell carcinoma: diagnostic and treatmentVOOG, E; BLAY, J.-Y.Bulletin du cancer. 1999, Vol 86, Num 7-8, pp 625-629, issn 0007-4551Article

Les sarcomes des tissus mous prise en charge multidisciplinaire et nouveaux conceptsFAYETTE, J; BLAY, J.-Y.Revue médicale suisse. 2005, Vol 1, Num 30, pp 1979-1984, issn 1660-9379, 5 p.Article

Imatinib rechallenge in patients with advanced gastrointestinal stromal tumorsBLAY, J.-Y; PEROL, D; LE CESNE, A et al.Annals of oncology. 2012, Vol 23, Num 7, pp 1659-1665, issn 0923-7534, 7 p.Article

Chirurgie des sarcomes et des tumeurs desmoïdes: retour sur une décennieBONVALOT, S; RIMAREIX, F.Oncologie (Paris). 2011, Vol 13, Num 12, issn 1292-3818, S176-S177, SUP6Article

Dix ans de GIST: de la maladie orpheline au modèle thérapeutiqueCASSIER, P. A.Oncologie (Paris). 2011, Vol 13, Num 12, issn 1292-3818, S184-S186, SUP6Article

Nouvelles approches dans les thérapeutiques ciblées : les récepteurs des facteurs de croissance de type insuline et les cyclines : Les thérapeutiques ciblées = New approaches to targeted therapies : insulin-like growth factors and cyclinsFLEURY, B; BLAY, J.-Y; FAYETTE, J et al.Oncologie (Paris). 2006, Vol 8, Num 9, pp 835-841, issn 1292-3818, 7 p.Article

Les thérapeutiques ciblées = Targeted treatments of cancerBLAY, J.-Y.Oncologie (Paris). 2003, Vol 5, Num 7-8, pp 351-356, issn 1292-3818, 6 p.Article

Correlation between overall survival and growth modulation index in pre-treated sarcoma patients: a study from the French Sarcoma GroupCOUSIN, S; BLAY, J. Y; CHAIGNEAU, L et al.Annals of oncology. 2013, Vol 24, Num 10, pp 2681-2685, issn 0923-7534, 5 p.Article

Limb salvage with isolated perfusion for soft tissue sarcoma : could less TNF-α be better?BONVALOT, S; LAPLANCHE, A; CAVALCANTI, A et al.Annals of oncology. 2005, Vol 16, Num 7, pp 1061-1068, issn 0923-7534, 8 p.Article

Results of a randomised phase II study comparing docetaxel with methotrexate in patients with recurrent head and neck cancerGUARDIOLA, E; PEYRADE, F; BLAY, J. Y et al.European journal of cancer (1990). 2004, Vol 40, Num 14, pp 2071-2076, issn 0959-8049, 6 p.Article

Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma GroupSVANCAROVA, L; BLAY, J. Y; HOGENDOORN, P. C. W et al.European journal of cancer (1990). 2002, Vol 38, Num 4, pp 556-559, issn 0959-8049Article

Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas : A trial of the european organization for research and treatment of cancer/soft tissue and bone sarcoma groupLE CESNE, A; JUDSON, I; VAN OOSTEROM, A et al.Journal of clinical oncology. 2000, Vol 18, Num 14, pp 2676-2684, issn 0732-183XArticle

Intravenous interleukin-2 in patients over 65 with metastatic renal carcinomaNEGRIER, S; MERCATELLO, A; MOSKOVTCHENKO, J. F et al.British journal of cancer. 1992, Vol 65, Num 5, pp 723-726, issn 0007-0920Article

Resistance to cytotoxic chemotherapy induced by CD40 ligand in lymphoma cellsVOORZANGER-ROUSSELOT, N; FAVROT, M.-C; BLAY, J.-Y et al.Blood. 1998, Vol 92, Num 9, pp 3381-3387, issn 0006-4971Article

Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic studyGELDERBLOM, H; BLAY, J. Y; MARREAUD, S et al.European journal of cancer (1990). 2014, Vol 50, Num 2, pp 388-396, issn 0959-8049, 9 p.Article

High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trialBUI-NGUYEN, B; RAY-COQUARD, I; THYSS, A et al.Annals of oncology. 2012, Vol 23, Num 3, pp 777-784, issn 0923-7534, 8 p.Article

Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcomaGRONCHI, A; BUI, B. N; PEREZ, I et al.Annals of oncology. 2012, Vol 23, Num 3, pp 771-776, issn 0923-7534, 6 p.Article